Trial Profile
An Open-Label Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 in Healthy Subjects Following a Single Oral Dose Administration of 14C-JNJ-38518168
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2013
Price :
$35
*
At a glance
- Drugs Toreforant (Primary)
- Indications Asthma; Pruritus; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 04 Nov 2013 New trial record